Drug Approval | November 08, 2023
Lupin receives USFDA tentative approval for Canagliflozin and Metformin Hydrochloride ER Tablets
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin’s Pithampur facility in India
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
This product will be manufactured at Lupin's Nagpur facility in India
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
Subscribe To Our Newsletter & Stay Updated
